VK

Vatchala Kumaravelan

Active Director Director DIN 07230171
DIN 07230171 First appointment Jul 2015 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Jul 2015
Shareholding value •••• Premium profile

About Vatchala Kumaravelan

Data last updated:

Vatchala Kumaravelan is a Director at Sri Aruna Global Exim Private Limited (since 2019), Director at Casomed Pharmaceuticals Private Limited (since 2016) and Managing Director at Aruna Natural Stones Private Limited (since 2019), and holds 1 more current directorship. The companies operate in Trading, Pharma and Mining. The 2 current companies with reported revenue have a combined latest revenue of ₹82.5 Lakh; the largest is Sri Aruna Global Exim Private Limited at ₹60.5 Lakh (FY 2022). Earlier, Vatchala Kumaravelan was a Director at Heal Bio-Care Private Limited (2016–2020) and Managing Director at Aruna Shelters Private Limited (from 2017).

DIN 07230171
Primary Designation Director
Industry Trading
First Appointment 14 Jul 2015
Oldest Company Age 11 yrs
Largest company Sri Aruna Global Exim Private Limited · ₹60.5 Lakh (FY 2022)
Combined revenue ₹82.5 Lakh across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Dec 20192019₹60.5 Lakh (FY 2022)Active
Director03 Feb 20162016₹22 Lakh (FY 2022)Active
Aruna Natural Stones Private Limited U14294TN2019PTC133092
Managing Director10 Dec 20192019Active
Director14 Jul 20152015Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Heal Bio-Care Private Limited U24290TN2016PTC110540
Director24 May 20162016Active
Aruna Shelters Private Limited U45309TN2017PTC115883
Managing Director05 Apr 20172017Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aruna Natural Stones Private Limited
Aruna Shelters Private Limited
Casomed Pharmaceuticals Private Limited
Sri Aruna Global Exim Private Limited
Premium access

Shareholding and investment profile for Vatchala Kumaravelan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vatchala Kumaravelan

Vatchala Kumaravelan currently holds 4 directorships: Sri Aruna Global Exim Private Limited (Director, since 19 Dec 2019, revenue ₹60.5 Lakh (FY 2022)); Casomed Pharmaceuticals Private Limited (Director, since 03 Feb 2016, revenue ₹22 Lakh (FY 2022)); Aruna Natural Stones Private Limited (Managing Director, since 10 Dec 2019); Mother Care Global Health India Private Limited (Director, since 14 Jul 2015).

Vatchala Kumaravelan was first appointed on 14 Jul 2015 as Director at Mother Care Global Health India Private Limited. The most recent appointment on record is 19 Dec 2019 at Sri Aruna Global Exim Private Limited.

The 2 current companies of Vatchala Kumaravelan that report revenue have a combined latest revenue of ₹82.5 Lakh: Sri Aruna Global Exim Private Limited ₹60.5 Lakh (FY 2022); Casomed Pharmaceuticals Private Limited ₹22 Lakh (FY 2022).

Vatchala Kumaravelan held 2 earlier board appointments: Heal Bio-Care Private Limited (Director, 24 May 2016 to 04 Sep 2020); Aruna Shelters Private Limited (Managing Director, from 05 Apr 2017).

The current boards of Vatchala Kumaravelan's companies include Kumaravelan Arunasre (Sri Aruna Global Exim Private Limited), Gowri (Mother Care Global Health India Private Limited), Vijayalakshmi (Mother Care Global Health India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available